Cargando…

Recent clinical trends in Toll‐like receptor targeting therapeutics

Toll‐like receptors (TLRs) are germline‐encoded receptors that are central to innate and adaptive immune responses. Owing to their vital role in inflammation, TLRs are rational targets in clinics; thus, many ligands and biologics have been reported to overcome the progression of various inflammatory...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anwar, Muhammad Ayaz, Shah, Masaud, Kim, Jason, Choi, Sangdun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587958/ https://www.ncbi.nlm.nih.gov/pubmed/30450666 http://dx.doi.org/10.1002/med.21553

Ejemplares similares

Toll-like Receptor-Dependent Negative Effects of Opioids: A Battle between Analgesia and Hyperalgesia
por: Shah, Masaud, et al.
Publicado: (2017)

Negative regulatory approaches to the attenuation of Toll-like receptor signaling
por: Anwar, Muhammad Ayaz, et al.
Publicado: (2013)

Multiple Roles of Toll-Like Receptor 4 in Colorectal Cancer
por: Yesudhas, Dhanusha, et al.
Publicado: (2014)

Toll-Like Receptors as a Therapeutic Target in the Era of Immunotherapies
por: Farooq, Mariya, et al.
Publicado: (2021)

Insights into the species-specific TLR4 signaling mechanism in response to Rhodobacter sphaeroides lipid A detection
por: Anwar, Muhammad Ayaz, et al.
Publicado: (2015)

A structural insight into the negative effects of opioids in analgesia by modulating the TLR4 signaling: An in silico approach
por: Shah, Masaud, et al.
Publicado: (2016)

In silico mechanistic analysis of IRF3 inactivation and high-risk HPV E6 species-dependent drug response
por: Shah, Masaud, et al.
Publicado: (2015)

Toll-Like Receptors and Relevant Emerging Therapeutics with Reference to Delivery Methods
por: Javaid, Nasir, et al.
Publicado: (2019)

Toll-like Receptor Mediation in SARS-CoV-2: A Therapeutic Approach
por: Manan, Abdul, et al.
Publicado: (2022)

Structural Mechanism behind Distinct Efficiency of Oct4/Sox2 Proteins in Differentially Spaced DNA Complexes
por: Yesudhas, Dhanusha, et al.
Publicado: (2016)

Therapeutic Applications of Nucleic Acids and Their Analogues in Toll-like Receptor Signaling
por: Gosu, Vijayakumar, et al.
Publicado: (2012)

Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control
por: Durai, Prasannavenkatesh, et al.
Publicado: (2015)

Toll-like Receptors from the Perspective of Cancer Treatment
por: Javaid, Nasir, et al.
Publicado: (2020)

Molecular Interactions Between Innate and Adaptive Immune Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications
por: Haseeb, Muhammad, et al.
Publicado: (2018)

Unraveling the Tomaralimab Epitope on the Toll-like Receptor 2 via Molecular Dynamics and Deep Learning
por: Ahmad, Bilal, et al.
Publicado: (2022)

A Computational Probe into the Structure and Dynamics of the Full-Length Toll-Like Receptor 3 in a Phospholipid Bilayer
por: Patra, Mahesh Chandra, et al.
Publicado: (2020)

Oceans as a Source of Immunotherapy
por: Ahmad, Bilal, et al.
Publicado: (2019)

Recent Advances in Toll Like Receptor-Targeting Glycoconjugate Vaccines
por: Li, Qingjiang, et al.
Publicado: (2018)

Gram-Negative Marine Bacteria: Structural Features of Lipopolysaccharides and Their Relevance for Economically Important Diseases
por: Anwar, Muhammad Ayaz, et al.
Publicado: (2014)

Structure-Activity Relationship in TLR4 Mutations: Atomistic Molecular Dynamics Simulations and Residue Interaction Network Analysis
por: Anwar, Muhammad Ayaz, et al.
Publicado: (2017)

Structure and dynamic behavior of Toll‐like receptor 2 subfamily triggered by malarial glycosylphosphatidylinositols of Plasmodium falciparum
por: Durai, Prasannavenkatesh, et al.
Publicado: (2013)

In Silico Approach to Inhibition of Signaling Pathways of Toll-Like Receptors 2 and 4 by ST2L
por: Basith, Shaherin, et al.
Publicado: (2011)

Comparative Analysis of Species-Specific Ligand Recognition in Toll-Like Receptor 8 Signaling: A Hypothesis
por: Govindaraj, Rajiv Gandhi, et al.
Publicado: (2011)

Association of BUD13-ZNF259-APOA5-APOA1-SIK3 cluster polymorphism in 11q23.3 and structure of APOA5 with increased plasma triglyceride levels in a Korean population
por: Kim, Han-Kyul, et al.
Publicado: (2019)

Molecular Modeling-Based Evaluation of hTLR10 and Identification of Potential Ligands in Toll-Like Receptor Signaling
por: Govindaraj, Rajiv Gandhi, et al.
Publicado: (2010)

Toll-Like Receptors as Novel Therapeutic Targets for Ovarian Cancer
por: Muccioli, Maria, et al.
Publicado: (2012)

Toll-like receptor 2: therapeutic target for gastric carcinogenesis
por: McCormack, William, et al.
Publicado: (2012)

Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
por: Xun, Yang, et al.
Publicado: (2021)

Structural mechanism of DNA-mediated Nanog–Sox2 cooperative interaction
por: Yesudhas, Dhanusha, et al.
Publicado: (2019)

Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives
por: Sun, Hao, et al.
Publicado: (2022)

Computational Insight Into the Structural Organization of Full-Length Toll-Like Receptor 4 Dimer in a Model Phospholipid Bilayer
por: Patra, Mahesh Chandra, et al.
Publicado: (2018)

Recent Progress in the Molecular Recognition and Therapeutic Importance of Interleukin-1 Receptor-Associated Kinase 4
por: Patra, Mahesh Chandra, et al.
Publicado: (2016)

P176S Mutation Rewires Electrostatic Interactions That Alter Maspin Functionality
por: Anwar, Muhammad Ayaz, et al.
Publicado: (2023)

Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization
por: Shah, Masaud, et al.
Publicado: (2020)

Toll-Like Receptors as Therapeutic Targets in Central Nervous System Tumors
por: Abarca-Merlin, D. M., et al.
Publicado: (2019)

Role of Toll-Like Receptors in Neuroimmune Diseases: Therapeutic Targets and Problems
por: Li, Haixia, et al.
Publicado: (2021)

Correction: Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives
por: Sun, Hao, et al.
Publicado: (2022)

Toll-like Receptor 2: A Novel Therapeutic Target for Ischemic White Matter Injury and Oligodendrocyte Death
por: Choi, Jun Young, et al.
Publicado: (2017)

Toll-Like Receptor Signaling Pathways: Novel Therapeutic Targets for Cerebrovascular Disorders
por: Ashayeri Ahmadabad, Rezan, et al.
Publicado: (2021)

Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer's Disease
por: Wu, Linyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9ji9c57mbqd1q38cesq7ulivtg